Artal Group S.A. - TRILLIUM THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Artal Group S.A. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$24,250,000
-9.7%
2,500,0000.0%0.49%
+3.8%
Q1 2021$26,850,000
-13.1%
2,500,000
+19.0%
0.47%
-28.5%
Q4 2020$30,891,000
+44.9%
2,100,000
+40.0%
0.66%
+28.2%
Q3 2020$21,315,000
+176.5%
1,500,000
+57.4%
0.52%
+139.4%
Q2 2020$7,710,000
+90.8%
953,000
-4.7%
0.22%
+26.3%
Q1 2020$4,040,000
+3980.8%
1,000,000
+566.7%
0.17%
+4175.0%
Q1 2019$99,000
-61.5%
150,0000.0%0.00%
-60.0%
Q4 2018$257,000
-70.5%
150,0000.0%0.01%
-56.5%
Q3 2018$870,000
-3.3%
150,0000.0%0.02%
+21.1%
Q2 2018$900,000
-16.7%
150,0000.0%0.02%
+35.7%
Q1 2018$1,080,000
-0.7%
150,0000.0%0.01%
-12.5%
Q4 2017$1,088,000150,0000.02%
Other shareholders

There were no reported owners of TRILLIUM THERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of TRILLIUM THERAPEUTICS INC shareholders